| |
|
The
functional and stereotactic neurosurgery program will be
featured in the next alumni Newsletter
|
|
"I
have great role models…the whole environment fosters
the development of young investigator-clinicians."
|
|
| Dr.
Emad N. Eskandar Director of Functional and Stereotactic Neurosurgery |
| Dr.
Emad N. Eskandar is the new Director of Functional and Stereotactic
Neurosurgery at MGH.
After
completing his residency at Mass General in 1999, Dr. Eskandar
joined the clinical faculty as an Assistant in Neurosurgery.
He
is a leader, both in his clinical endeavors, and as a Principal
Investigator at the MGH Laboratory for Sensorimotor Integration.
Dr. Eskandar's work focuses on the functional circuitry
involved in motor control in
|
order
to provide better treatment for Parkinson's disease and other
movement disorders.
Dr. Eskandar is eager to expand and develop the functional
and stereotactic neurosurgery program. He notes: "It's
exciting to work in MGH Neurosurgery, where there is such
a rich opportunity for research that can help to improve
our patients lives.
"The
support that I receive here is unparalleled." said
Dr. Eskandar
|
 |
| Dr.
William Curry Joins Faculty, receives NREF Grant |
 |
Dr.
William T. Curry, Jr. who completed his residency at MGH in
2002, has won an NREF Young Clincian's Award for 2005. The
award was created by the Neurosurgery Research and Education
Foundation of the AANS in 1985 to support rising clinician-investigators
by funding pilot studies. Dr. Curry joined the MGH staff in
2003, and is researching the development of novel biological
and immunologic therapies for malignant glioma. |
"Overcoming
immunological tolerance to tumor cells is the ultimate goal
of cancer immunotherapy," said Dr. Curry, adding "Low
levels of tumor-cell MHC and an immunosuppressive tumor
microenvironment allow the growth of cancer cells that escape
innate immunity. G207 (engineered by Dr. Martuza and collaborators)
is a multimutated replication- conditional herpes simplex-1
that selectively replicates in tumor cells, has attenuated
neurovirulence, and
|
| Dr.
Jeffrey Macklis receives Senator Javits Award |
| The
National Institutes of Neurological Disorders and Stroke (NINDS)
has awarded one of eight Senator Jacob Javits Award in the
Neurosciences to Jeffrey D. Macklis, HMS Associate Professor
of Neurology at Massachusetts General Hospital. Macklis will
receive |
seven
years of funding from the NINDS, a component of the National
Institutes of Health.
Dr.
Macklis has made significant contributions to the understanding
of neuronal replacement and cellular repair of the brain
following injury. His research shows that, contrary
|
to
previously held beliefs, the reconstruction of complex networks
in the brain's cerebral cortex can be achieved in adulthood.
He hopes to identify the best conditions for the integration
of neurons into existing networks of the
|
|
